Inventor · disambiguated record
Morag Helen Stewart
Also filed as: STEWART MORAG · STEWART MORAG H · STEWART MORAG HELEN
9 granted patents·15 pending applications·73 citations·filing 2016–2023
88Inventor score
Files withFLAGSHIP PIONEERING INNOVATIONS VI LLC15NOVARTIS AG6CHILDRENS MEDICAL CENTER2INTELLIA THERAPEUTICS INC1
Top patents by PatentIndex Score
24 records- 0196US11458156B2Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Granted Oct 4, 2022·10 cites·30 claims
- 0296US11160822B2Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Granted Nov 2, 2021·10 cites·30 claims
- 0396US11058706B2Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Granted Jul 13, 2021·17 cites·30 claims
- 0496US10953033B2Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2019·Granted Mar 23, 2021·19 cites·36 claims
- 0595US11844759B2Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Granted Dec 19, 2023·2 cites·30 claims
- 0692US10669528B2Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenanceCHILDRENS MEDICAL CENTER·Filed 2016·Granted Jun 2, 2020·13 cites·21 claims
- 0788US2024122959A1Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Application pending·0 cites
- 0883US12037583B2Compositions and methods for immunooncologyNOVARTIS AG·Filed 2016·Granted Jul 16, 2024·2 cites·55 claims
- 0971US2024417722A1Compositions and methods for immunooncologyNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1070US2025109401A1Compositions and methods for immunooncologyNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1166US2024002843A1Compositions and methods for the treatment of hemoglobinopathiesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1265US11891625B2Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenanceCHILDRENS MEDICAL CENTER·Filed 2020·Granted Feb 6, 2024·0 cites·19 claims
- 1361US11851659B2Compositions and methods for immunooncologyNOVARTIS AG·Filed 2018·Granted Dec 26, 2023·0 cites·44 claims
- 1461US2023083717A1Methods and compositions for promoting adipocyte beigingFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 1560US2024360411A1Methods and compositions for inducing fetal hemoglobin, modulating erythroid cell lineages, and perturbing megakaryocyte lineagesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 1657US2024374592A1Methods and compositions for perturbing monocyte and neutrophil lineagesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 1756US2023077584A1Methods and compositions for modulating enteroendocrine cellsFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 1853US2024361301A1Methods and compositions for modulating goblet cells and for muco-obstructive diseasesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 1951US2022142896A1Polyribonucleotides and cosmetic uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2020·Application pending·0 cites
- 2051US2022257794A1Circular rnas for cellular therapyFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2020·Application pending·0 cites
- 2150US2021292761A1Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2019·Application pending·0 cites
- 2249US2022088049A1Compositions, methods, and kits for delivery of polyribonucleotidesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2020·Application pending·0 cites
- 2345US2020308603A1In vitro method of mrna delivery using lipid nanoparticlesINTELLIA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2442US2019010495A1Compositions and methods for the treatment of hemoglobinopathiesNOVARTIS AG·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →